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Abstract
Background: Chronic fatigue is present in more than 60% of the patients with a neuromuscular disease and can
be their most disabling symptom. In combination with other impairments, fatigue often results in low levels of
physical activity and decreased social participation, leading to high societal costs. ‘Energetic’ is a self-management
group program aimed at improving social participation, physical endurance and alleviating fatigue in these patients.
The primary aim of this study is to evaluate the effectiveness and cost-effectiveness of the Energetic program.
Methods/Design: A multicentered, assessor-blinded, two-armed randomized controlled trial is conducted with
evaluations at inclusion and four, seven and fifteen months later. The study includes patients with a neuromuscular
disease and chronic fatigue and, when present, their caregivers. The participants are randomized (ratio 1:1) to
either an intervention group, receiving the Energetic program, or a control group, receiving usual care (i.e., no
specific intervention). The Energetic program covers four months and includes four modules: 1) individually
tailored aerobic exercise training; 2) education about aerobic exercise; 3) self-management training in applying
energy conservation strategies; and 4) implementation and relapse prevention in daily life. Two months after
cessation of the program a booster session is provided. The primary outcome is the perceived performance score
of the Canadian Occupational Performance Measure (COPM). Secondary outcomes include the COPM-satisfaction
score, and measures of fatigue, physical endurance, activity engagement, mood, and self-efficacy. Caregiver burden
is also evaluated as a secondary outcome. Health-related quality of life and medical and societal costs are assessed
to estimate cost-effectiveness of the program.
Discussion: The Energetic study is the first randomized controlled trial to evaluate the effectiveness and cost-
effectiveness of a combined physical and self-management group training program for improving social participation,
physical endurance and alleviating fatigue in patients with neuromuscular diseases. It will generate new insights in
(cost-)effective rehabilitation strategies for these incurable conditions.
Trial registration: Clinicaltrials.gov NCT02208687.
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Background
Chronic fatigue is present in more than 60% of pa-
tients with a neuromuscular disease (NMD), including
facioscapulohumeral muscular dystrophy (FSHD), in-
clusion body myositis (IBM) and mitochondrial myop-
athies (MM), and can be their most prominent and
disabling symptom [1,2]. In combination with muscle
weakness, enhanced fall risk, and possible cardiopul-
monary involvement, fatigue often results in low levels
of physical activity and decreased social participation,
which in turn leads to high societal costs. Compared
to other neurological conditions, NMDs have the
highest estimated costs of €30.000,- per person per
year, with an estimated prevalence between 1:20.000 to
1:424 persons [3,4]. These include direct health costs
related to treatment and rehabilitation, indirect costs
related to low employment rates due to work absence
or early retirement, and non-medical costs for social
services, assistive devices and informal care [5].
In a recent randomized controlled trial, we have pro-
vided evidence that aerobic exercise training and cogni-
tive behaviour therapy can both alleviate severe chronic
fatigue in patients with FSHD [6]. Both interventions
were based on a theoretical model of chronic fatigue in
NMD, in which muscle strength, level of self-reported
physical activity, sleep disturbances and pain were all
associated with fatigue and, ultimately, with social par-
ticipation [7]. Based on the first research results and
experiences in patients with FSHD, we developed a
multidisciplinary rehabilitation program to accommo-
date the clinical urge felt by many (other) patients with
NMD and chronic fatigue. This rehabilitation program
was called ‘Energetic’ and combines aerobic exercises
and energy-conservation strategies in a self-management
group program to improve social participation and phys-
ical endurance and alleviate fatigue. The program covers
four months and includes four modules: (1) aerobic
exercise training, (2) education about aerobic exercise,
(3) self-management training in applying energy conser-
vation strategies, and (4) implementation and relapse
prevention in daily life. In the development of the pro-
gram, we have acknowledged the research priorities
identified by patients with NMD and healthcare profes-
sionals [8], and implemented the available clinical evi-
dence regarding exercise training in NMD [6,9,10], fatigue
management [11,12] and self-management training [13].
The following dimensions of self-management are ad-
dressed in the Energetic program; (1) medical manage-
ment (e.g., regarding medication, diet or exercise (2) role
management (regarding meaningful social roles), and (3)
emotional management (dealing with emotions such as
fear or depression) [13]. Self-management programs pro-
vide patients with the necessary knowledge, skills, and
confidence (‘self-efficacy’) to manage life with a chronic
illness and prepares patients to collaborate with their
healthcare professionals and the healthcare system [13].
Although the Energetic program was well appreciated
by participants already from the beginning, it has not yet
been formally evaluated. So far, we only conducted an
uncontrolled pilot study with pre-post measurements in
13 patients with a neurological condition (77% NMD)
showing significant improvement in social participation
based on the Canadian Occupational Performance Meas-
ure (COPM) and a significant decrease in fatigue as
assessed with the Checklist Individual Strength - subscale
Fatigue (CIS-Fatigue) [14]. These promising results formed
the basis to conduct the present larger randomized
controlled trial of the (cost-) effectiveness of the Ener-
getic program in various forms of NMD, specifically
FSHD, IBM and MM. In this study, the hypothesis is
tested that the Energetic program results in improved
social participation, better physical endurance and less
fatigue in patients with NMD and severe chronic fatigue
compared to no specific intervention (‘usual care’). Fur-
thermore, we expect that these improvements will ultim-
ately lead to a reduction in medical and societal costs.
Methods/Design
A multicentered, assessor-blinded, two-armed random-
ized controlled trial is conducted, in which eligible
patients are randomized in a 1:1 ratio to either an inter-
vention group, receiving the Energetic program, or a
control group, receiving no specific intervention (‘usual
care’). Randomization is based on a computerized
minimization algorithm with the following minimization
factors: gender, work (work ≥ no work), diagnosis
(FSHD, IBM, MM, ≥ other NMD). Data will be collected
at inclusion (before randomization, T0), at the end of
the program (4 months after inclusion, T1), at three
months follow-up (7 months after inclusion, T2), and at
eleven months follow-up (15 months after inclusion, T3)
(see Figure 1). Fifteen months after inclusion, the control
group is offered participation in the Energetic program,
but this post-study intervention period is not monitored.
All outcomes are assessed by blinded and independ-
ent occupational therapy research assistants. At the be-
ginning of each assessment, participants are instructed
not to reveal their group allocation to the assessor.
After each assessment, blinding of the assessors is eval-
uated by asking them to indicate their idea of group as-
signment for each patient. Data entry is executed by
the (blinded) research assistant. Adverse events or ir-
regularities affecting protocol adherence are registered
by the primary researcher (YV). Full ethical approval
has been granted by the medical ethical committee of
Arnhem-Nijmegen (NL47624.091.14) and all participat-
ing centers granted (ethical) approval to participate.
Veenhuizen et al. BMC Neurology  (2015) 15:58 Page 2 of 8
The Energetic study has been registered at clinical-
trial.gov (NCT02208687).
Setting
Patients are recruited at either the departments of Re-
habilitation, Neurology or General Internal Medicine of
the Radboud University Medical Centre or at a major re-
gional rehabilitation center (RMC Groot Klimmendaal). In
addition, the Dutch NMD patient association ‘Spierziekten
Nederland’ facilitates patient recruitment by posting infor-
mation about the study on their website, in their magazine,
and by sending mails to the specific patient groups (FSHD,
IBM, MM). Based on patient preference, the Energetic
program is offered and evaluated in one of the follow-
ing three settings: Radboud University Medical Centre
(Nijmegen), RMC Groot Klimmendaal (Arnhem), and
community health center Buitenlust (Venray). Three
intervention groups are planned in Nijmegen, three
groups in Arnhem, and one group in Venray. Interven-
tion groups consist of four to seven patients.
Participants
Referred or otherwise interested patients are contacted
by telephone by the primary investigator (YV) to provide
Figure 1 Flow chart of the Energetic study.
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detailed information about the content of the study, the
informed consent procedure, and to answer any re-
sidual questions related to study participation. The pri-
mary informal caregiver of the patient is also asked to
participate in the study when willing and available.
When patients and caregivers express their willingness
to participate and global screening of the inclusion and
exclusion criteria indicates potential eligibility, appoint-
ments for visits with a rehabilitation physician and oc-
cupational therapist at the outpatient rehabilitation
clinic of the Radboud University Medical Centre are
made. During these visits the inclusion and exclusion
criteria are thoroughly checked and the informed con-
sent is signed.
Table 1 provides an overview of the applied inclusion
and exclusion criteria. All patients should be at least 18
years old and have an established neuromuscular disease,
preferably FSHD, IBM, or MM. They should suffer from
chronic fatigue with a clear influence on their social par-
ticipation. They should also be motivated for participa-
tion in the Energetic program and show ‘readiness to
change’. The latter aspects are tested by motivational
interviewing [15], without the use of any formal cut-off
criteria. In addition, each patient has to be able to for-
mulate at least three personalized goals with regard to
social participation. Possible depressive symptoms and
other psychiatric or cognitive symptoms are judged by
the psychologist for their severity to determine whether
patients can participate in the Energetic program.
Upon inclusion, the following socio-demographic char-
acteristics are registered in a questionnaire: age (years),
gender (male/female), living together (yes/no), level of
education (low, middle, high), employment status (yes/
no), relationship with caregiver (partner/sibling/ child/
friend). In addition, patients’ diagnoses and years of diag-
noses are recorded. Patients’ self-reported knowledge,
skills and confidence with regard to self-management of
their disease are registered with the Patient Activation
Measure (PAM) [16].
Intervention
The Energetic program is administered in small groups
of minimally four and maximally seven patients. Al-
though it is a group program, aerobic exercise training
and self-management strategies are individualized as
much as possible. At all settings, the program is deliv-
ered by a physical therapist and an occupational therap-
ist, both experienced with behavioural modification
techniques, and consists of the following modules:
Aerobic exercise training
During four months (16 weeks) patients receive indi-
vidually tailored aerobic exercise training from the
physical therapist, amounting to sessions of 90 minutes
with regular breaks as needed; during the first 9 weeks
twice a week and during the last 7 weeks once weekly.
Patients are expected to perform physical exercises
themselves once and twice a week during these periods,
respectively, so that that the overall physical training
load amounts to three sessions of at least 30 minutes
per week during the entire intervention period. Train-
ing intensity is aimed at 50-70% of the maximum heart
rate, guided by a cardiac rhythm monitor mounted on
the chest that is read out by a wrist watch. Fine tuning
takes place based on the recovery rate. The training in-
cludes different exercises, such as walking on a tread-
mill, cycling on a home trainer, rowing, and using a
cross trainer, depending on the preference and motor
abilities of the individual.
Education about aerobic exercise
In three 60-minute sessions (weeks 2-4), patients are
taught about general training principles by the physical
therapist. During these sessions the following training
principles are addressed: (1) attaining an adequate train-
ing stimulus, (2) the need to rest and recuperate, (3) de-
signing and adhering to a feasible training program, and
Table 1 Inclusion and exclusion criteria of the Energetic study
Inclusion criteria Exclusion criteria
1) Age 18 years and older 1) Cardiorespiratory problems that preclude participation in aerobic
exercise training
2) Having one of the following chronic degenerative muscle diseases:
facioscapulohumeral muscular dystrophy (FSHD), inclusion body myositis
(IBM), mitochondrial myopathy, or other muscle disease
2) Severe cognitive impairment
3) Suffering from fatigue with an impact on daily occupation* 3) Depression or other psychiatric disorder, including addiction problems
4) Being motivated and ‘ready to change’* 4) Pregnancy
5) Being able to formulate at least three personalized participation goals* 5) Limited life expectancy (<5 years) due to known co-morbid condition
6) Having participated in the Energetic (or similar) program before
*Assessed by Motivational Interviewing.
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(4) prevention of overtraining and relapse. Besides em-
phasizing relapse prevention, patients are taught that
relapse cannot entirely be prevented (e.g., after a flu)
especially not when living with a chronic illness.
Self-management training in applying energy conservation
strategies
During eight 90-minute sessions (weeks 2-8 and 10),
training in energy conservation strategies is given by the
occupational therapist. These sessions are based on an
evidence-based program for patients with multiple
sclerosis, including education, discussion, goal setting,
practicing activities, and performing homework activ-
ities with the aim to teach patients how to integrate
energy conservation strategies into their daily lives.
[11]. The following energy conservation strategies are
addressed:
(1) benefits of rests, (2) effectively communicating with
the social environment, (3) applying principles of proper
body mechanics and ergonomics, (4) adequately modify-
ing the personal environment, (5) analyzing and adjusting
individual activities, (6) setting priorities, (7) finding an
activity-rest balance over the entire day and week, (8) set-
ting short-term and long-term goals, and (9) careful plan-
ning of activities to achieve one’s personal goals.
Implementation and relapse prevention in daily life
During ten 60-minute sessions (weeks 5-13 and 16), the
physical and occupational therapists support and em-
power the patients in implementation of the aerobic ex-
ercise training and energy conservation strategies into
their daily lives until they are sufficiently able to main-
tain these skills. One session is specifically devoted to
the preparation of healthy food and is provided by a diet-
ician, while another session, provided by an occupational
therapist, is specifically focused on self-management at
work. Caregivers are involved in two sessions in which pa-
tients are encouraged to think about how to maintain
their level of physical endurance after cessation of the
intervention. During this module different types of exer-
cise are explored and guided by sports trainers and phys-
ical therapists, such as swimming, Nordic walking, yoga,
and body work-out. Patients are also stimulated to explore
possibilities for exercising in their own environment and
share these experiences with group members. The ultim-
ate goal for each patient is to have a feasible home-
exercise program encompassing at least three days a week.
In order to check whether patients are indeed able to
maintain their achieved level of physical activity and exer-
cise, a booster session of two hours with the physical and
occupational therapists is organized two months after the
end of the intervention program to reinforce previously
learned skills.
A typical day program lasts at least three hours and en-
compasses aerobic exercise training and one of the other
modules, including a 45-minute break (see Table 2). Indi-
vidual therapy compliance is recorded by the therapists
with regard to both the attendance of training sessions,
education sessions, and participation in homework assign-
ments. Whenever applicable, patients are asked for their
reasons for noncompliance or drop-out.
Before the start of the study, the participating phys-
ical and occupational therapists in each clinical setting
follow a specific training how to deliver the Energetic
program and adopt a self-management approach. This
training consists of theoretical education as well as
teaching practical skills at Energetic group sessions.
During the study period, two sessions are organized for
all therapists to reinforce their learned skills, to reflect
on the program, and to share information among one
another. At any point during the study, therapists are
stimulated to contact each other to share experiences
and consult the primary investigator whenever neces-
sary (YV).
Usual care consists of continuation of every-day life,
which often means regular physical therapy or some-
times no intervention at all [17]. In both the experimen-
tal and control groups, all (additional) interventions are
monitored during the study period. The consultation of
healthcare and social support professionals is recorded
with a healthcare-utilization questionnaire at every as-
sessment focusing on the preceding months. Patients are
not restricted in any activities.
Outcome measures
All primary and secondary outcome measures for deter-
mining the effectiveness of the Energetic program are
listed in Table 3. The primary outcome is the patient’s
self-rated performance in three to five self-identified
problematic daily occupations assessed with the Canadian
Occupational Performance Measure (COPM-perform-
ance) [18]. The COPM is a semi-structured interview
designed to help patients to identify problems in their
occupational performance using a structured scoring
method. The patient has to put forward a minimum of
three and maximum of five problematic daily occupations.
Table 2 Typical day within the Energetic program
Time Modules
11.00 – 12.30 Aerobic exercise training
12.30 – 13.15 Break; including lunch and taking a shower
13.15 – 14.15/14.45 Group session
a. Education on aerobic exercise training, or
b. Fatigue management with energy conservation
strategies, or
c. Implementation and relapse prevention
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These occupations are subsequently rated on a 10-point
scale for perceived performance capacity (1 = not able at
all, 10 = perfectly able). Previous studies have shown that
the COPM is a valid and responsive instrument to assess
self-care, productivity and leisure and patients’ perspec-
tives related to these activities [19,20].
Secondary measures of effectiveness include the COPM-
satisfaction score (1 = not satisfied at all, 10 = extremely
satisfied) [18-20], Checklist Individual Strength - subscale
fatigue (CIS-Fatigue) [21], physical endurance (6-Minute
Walking Test) [22], activity engagement (Activity Card
Sort) [23,24], mood (Hospital Anxiety and Depression
Scale) [25], and self-efficacy (General Self-Efficacy Scale)
[26]. At the level of the caregiver, secondary outcomes are
perceived caregiver burden (Zarit Burden Interview) [27]
and objective caregiver burden (Objective Care Burden
Questionnaire; a self developed scale for amount of care
(hours)).
Outcome measures in the economic evaluation are
costs (direct health costs and indirect societal costs) and
quality adjusted life years (QALY). The quality of the
health status of the patients is based on the Short Form-
36 Health Survey (SF-36) [28] and costs are based on a
self-developed resource utilization questionnaire.
Sample size calculation
The primary outcome is the change in COPM-performance
score at the end of the program (T1) since baseline
(T0). A conservative estimate of the improvement of
the Energetic group compared to usual care is set at
2.0 and the standard deviation of the change in each
group at 1.7. These numbers are based on the results
of our pilot study with 13 participants [14]. Based on
these assumptions, 13 participants are needed in each
group to obtain a power of 80% (two sided t-test set
5%). Taking into account a drop-out rate of 10%, a
total of 30 participants would be required. However, to
meet the required estimates for determining the cost-
effectiveness, our aim is to include 50 patients.
Statistical analysis
The primary variable for effectiveness will be analyzed in a
covariance model with the COPM-performance scores at
the end of the program (T1) as dependent variable. The
baseline COPM-performance (T0) and the minimization
factors will be covariates. Two-sided 95% confidence in-
tervals will be presented. Data will be analyzed following
the principle of intention-to-treat. Similarly, the secondary
variables will be evaluated.
The economic evaluation is based on the principles of a
cost-effectiveness (utility) analysis from a societal perspec-
tive. The primary incremental cost-effectiveness ratio is
the cost per QALY gained (ICER) based on SF-6D utilities
[29]. Uncertainty surrounding this ICER will be deter-
mined using the bootstrap method. A cost-effectiveness
acceptability curve will be derived that is able to evaluate
the probability that ‘Energetic’ is efficient against different
thresholds (Willingness To Pay) for a QALY.
Discussion
To the best of our knowledge, the Energetic study is the
first randomized controlled trial to evaluate the effect-
iveness and cost-effectiveness of a combined physical
and self-management group training program for im-
proving social participation, physical endurance and alle-
viating fatigue in patients with neuromuscular diseases
Table 3 Outcome measures
Participants Outcome Outcome measure
Patients Primary outcome measure
Social participation – performance of occupations Canadian Occupational Performance Measure, performance score
(COPM-performance) [18-20]
Secondary outcome measures
Social participation- satisfaction with occupational performance Canadian Occupational Performance Measure, satisfaction score
(COPM-satisfaction) [18-20]
Fatigue impact and severity Checklist Individual Strength - subscale Fatigue (CIS-Fatigue) [21]
Physical endurance 6-Minute Walking Test [22]
Activity engagement Activity Card Sort (ACS) [23,24]
Self-efficacy General Self-Efficacy Scale [26]
Mood Hospital Anxiety and Depression Scale (HADS) [25]
Resource utilization Self-developed resource utilization questionnaire
Health-related quality of life Health-related Quality of Life: Short Form 36 (SF-36) [28]
Caregiver(s) Perceived caregiver burden Zarit Burden Interview (ZBI) [27]
Objective caregiver burden Self-developed scale for objective care burden questionnaire; amount
of care (hours)
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(NMDs). We expect that this study will generate new in-
sights in (cost-) effective rehabilitation strategies for
these incurable conditions.
The current study includes patients with various forms
of NMD, but specifically focuses on patients with FSHD,
IBM and MM. These are all chronic degenerative muscle
diseases with a slowly progressive character. The com-
monality among these disorders is the struggle that pa-
tients experience to manage their lives with chronic
fatigue and reduced physical capacity. Although the study
is powered to establish (cost-)effectiveness across the dif-
ferent diagnoses, an attempt will be made to perform sub-
group analyses, using diagnosis as a between-subjects
factor, to detect trends in differences in effect sizes and
therapy compliance between groups. In addition, diversity
will be addressed by examining the influence of socio-
demographic characteristics on effect size and therapy
compliance.
As a primary outcome, we chose the COPM because this
measure potentially fits best with the self-management and
participation goals of the Energetic program. The COPM
assesses the perceived performance of daily activities as well
as the individual satisfaction with these activities, and has
shown to be a sensitive and clinically relevant outcome in
many other rehabilitation studies [30-33]. In addition, a
wide range of secondary outcome measures is used to fully
examine and understand the impact of the Energetic pro-
gram on the lives of patients with NMD and their care-
givers. The economic evaluation serves to underscore the
financial and societal impact of the program and to secure
future reimbursement by health insurances.
We purposively included three clinical settings for a
first implementation of the Energetic program: besides a
university medical center, we selected a regional rehabili-
tation center and a community health center. This
choice allows us to evaluate barriers and facilitators of
implementation in each of these settings, which will help
future dissemination of the Energetic program across
other health institutions. To this end, we will monitor
protocol adherence by therapists using a logbook,
organize booster sessions for therapists during the study,
and organize a group meeting with all therapists for
process evaluation after the study period.
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